Multiple autoimmune diseases in a young woman: Tuberculosis and splenectomy as possible triggering factors? Another example of the "mosaic" of autoimmunity

Journal of Rheumatology

Volumn 35, Issue 6, 2008, Pages 1224-1227

  Asherson, Ronald A ^a,b   Gunter, Karin ^c   Daya, Dharmesh ^b   Shoenfeld, Yehuda ^d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Netcare   (South Africa)

^c MAYO CLINIC   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PYRIDOSTIGMINE;

AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; ELECTROMYOGRAPHY; ENVIRONMENTAL FACTOR; ERYTHROCYTE SEDIMENTATION RATE; HEREDITY; HISTOLOGY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INNATE IMMUNITY; LETTER; MUSCLE ACTION POTENTIAL; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RISK ASSESSMENT; SJOEGREN SYNDROME; SPLENECTOMY; THROMBOCYTE COUNT; THYMECTOMY; THYMUS HYPERPLASIA; THYROIDITIS; TUBERCULOSIS; VITILIGO;

ADULT; ANTI-INFLAMMATORY AGENTS; FEMALE; HASHIMOTO DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; MYASTHENIA GRAVIS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; PURPURA, THROMBOTIC THROMBOCYTOPENIC; SPLENECTOMY; STEROIDS; SYNDROME; TUBERCULOSIS;

EID: 44949171744     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (40)

1. Brickman CM, Shoenfeld Y. The mosaic of autoimmunity. Scand J Clin Lab Invest 2001;61:3-15.
2. Amital H, Gershwin E, Shoenfeld Y. Reshaping the mosaic of autoimmunity. Semin Arthritis Rheum 2006;35:341-3.
3. Mevorach D, Perrot S, Buchanan NM, et al. Appearance of systemic lupus erythematosus after thymectomy; four case reports and review of the literature. Lupus 1995;4:33-7.
4. Levene NA, Varon D, Shtalrid M, Berrebi A. Chronic active hepatitis following splenectomy for autoimmune thrombocytopenia. Isr J Med Sci 1991;27:199-201.
5. Yamaike N, Saigo K, Imoto S, et al. Autoimmune hepatitis accompanied by idiopathic thrombocytopenic purpura and Sjogren's syndrome. Intern Med 2002;41:72.
6. Humbert P, Dupond JL. Multiple autoimmune syndromes. Ann Med Interne (Paris) 1988;139:159-68.
7. Somers EC, Thomas SI, Smeeth L, Hall AJ. Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology 2006;17:202-17.
8. Anaya J-M, Corena R, Castiblanco J, Rojas-Villarago A, Shoenfeld Y. The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity. Future Drugs 2007; (in press).
9. Weiss P, Shoenfeld Y. Shifts in autoimmune disease; the kaleidoscope of autoimmunity. Isr J Med Sci 1991;27:216-7.
10. Shoenfeld Y. The kaleidoscope of autoimmunity. Autoimmunity 1993;15:245-51.
11. Shoenfeld Y, Lorber M, Yucel T, Yazici H. Primary antiphospholipid syndrome emerging after thymectomy for myasthenia gravis: additional evidence for the kaleidoscope of autoimmunity. Lupus 1997;6:474-6.
12. Fishman P, Merlinsky O, Baharav E, Shoenfeld Y. Autoantibodies to tyrosine - the bridge between melanoma and vitiligo. Cancer 1997;79:1461-4.
13. Kemp EH, Waterman A, Weetman AP. Autoimmune aspects of vitiligo. Autoimmunity 2001;34:65-77.
14. Hegedus L, Heidenheim M, Gervil M, Hjalgrim H, Holer-Maddsen M. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol 1994;74:120-3.
15. Dervis E, Acbay O, Barut G, Karaoglu A, Ersoy L. Association of vitiligo, morphoea and Hashimoto's thyroiditis. Int J Dermatol 2004;43:236-7.
16. Montes LF, Pfister R, Elizalde F, Wilborn W. Association of vitiligo with Sjogren's syndrome. Acta Derm Venereol 2003;83:293.
17. McCann P, Pramanik A. Dysphagia and unexpected myasthenia gravis associated with primary biliary cirrhosis, ulcerative colitis and vitiligo. J Am Geriatr Soc 2004;52:1407-8.
18. Amerio P, Tracanna M, De Remigia P, et al. Vitiligo associated with other autoimmune diseases; polyglandular autoimmune syndrome types 3B+C and 4. Clin Exp Dermatol 2006;31:246-9.
19. Topaktas S, Dener S, Kenis M, Dalkara T. Myasthenia gravis and vitiligo. Muscle Nerve 1993;16:566-7.
20. Kubota A, Komiyama A, Tanigawa A, Hasigawa O. Frequency and correlates of vitiligo in myasthenia gravis. J Neurol 1997;244:388-9.
21. Cruz MW, Maranhao Filho PA, Andre C, Mattos JP, Novis SA. Myasthenia gravis and vitiligo. Muscle Nerve 1994;17:559-60.
22. Nath SK, Kelly JA, Namjou B, et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet 2001;6:1401-6.
23. Jin Y, Mailloux CM, Gowan K, et al. NALP1 in vitiligo-associated multiple autoimmune diseases. N Engl J Med 2007;356:1216-25.
24. Peacey SR, Belchetz PE. Graves' disease associated with ocular myasthenia gravis and thymic cyst. J R Soc Med 1993;86:297-8.
25. Marino M, Barbasino G, Manetti L, et al. Mild clinical expression of myasthenia gravis associated with autoimmune thyroid disease - author's response. J Clin Endocrinol Metab 1997;82:3905-6.
26. Szyper-Kravitz M, Marai A, Shoenfeld Y. Coexistence of thyroid autoimmunity with other autoimmune diseases: Friend or foe? Additional aspects of the mosaic of autoimmunity. Autoimmunity 2005;38:247-55.
27. Scofield H, Bruner R, Gail R, Harley JB. Autoimmune thyroid disease is associated with a diagnosis of secondary Sjogren's syndrome in familial systemic lupus. Ann Rheum Dis 2007;66:410-3.
28. Tishler M, Shoenfeld Y. Tuberculose et auto-immunite: ou en sommes-nous? Annals de L'Institute Pasteur 1996;7:133-6.
29. Shoenfeld Y, Wilner Y, Coates AR, Rauch J, Lavie G, Pinkhas J. Infection and autoimmunity: Monoclonal anti-tuberculosis antibodies react with DNA and monoclonal anti-DNA autoantibodies bind to mycobacterial derived glycolipids. Clin Exp Immunol 1986;66;255-61.
30. Sela O, El-Roeiy A, Isenberg DA, et al. A common anti-DNA antibody idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum 1987;30:50-5.
31. Isenberg DA, Maddison P, Swana G, et al. Profile of autoantibodies in the sera of patients with tuberculosis, Klebsiella and other gram-negative infections. Clin Exp Immunol 1987;67:516-23.
32. Teplizki H, Alkan M, Coates ARM, Shoenfeld Y. ELISA measurement of antibodies titer to PPD and mycobacteria derived phosphoglycolipids as an aiding tool to the diagnosis of active pulmonary tuberculosis. Isr J Med Sci 1987;23:1121-4.
33. Teplizki H, Buskila D, Alkan M, Coates ARM, Baumgarten A, Shoenfeld Y. Elisa measurements of antibody titer to purified protein derivative and mycobacteria-derived phosphoglycolipids: tool for diagnosing active pulmonary tuberculosis. Isr J Med Sci 1988;23:1121-4.
34. Teplizki H, Buskila D, Argov S, et al. Low serum antimycobacterial glycolipid antibody titers in the sera of patients with systemic lupus erythematosus associated with central nervous system involvement. J Rheumatol 1987;14:507-11.
35. Shoenfeld Y, Isenberg DA. Mycobacteria and autoimmunity. Immunol Today 1988;9:178-82.
36. Amital-Teplizki H, Avnoach I, Coates ARM, Kooperman O, Blank M, Shoenfeld Y. Binding of monoclonal anti-DNA and anti-TB glycolipid to brain tissue. Autoimmunity 1989;4:277-87.
37. Rahamim-Cohen D, Shoenfeld Y. The mosaic of autoimmunity. A classical case of inhalation of a polyclonal activating factor in a genetically and hormonally susceptible patient leading to multiple autoimmune diseases. Isr Med Assoc J 2001;3:381-2.
38. Shoenfeld Y, Isenberg D. The mosaic of autoimmunity. Research monographs on immunology. Vol 12. Amsterdam: Elsevier Science Publishers; 1989.
39. Shoenfeld Y, Isenberg D. The mosaic of autoimmunity. Immunol Today 1989;10:123-6.
40. Amital H, Shoenfeld Y. Autoimmunity and autoimmune diseases such as systemic lupus erythematosus. In: Lahita RG, editor. Systemic lupus erythematosus. 4th ed. Amsterdam: Elsevier; 2004:3-27.